Warning: The NCBI web site requires JavaScript to function. more...
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.
Monneaux F, Muller S.
Arthritis Res Ther. 2009;11(3):234. Epub 2009 Jun 30. Review.
Related citations
Update on emerging drug therapies for systemic lupus erythematosus.
Mok CC.
Expert Opin Emerg Drugs. 2010 Mar;15(1):53-70. Review.
Systemic lupus erythematosus trials: successes and issues.
Ginzler EM, Moldovan I.
Curr Opin Rheumatol. 2004 Sep;16(5):499-504. Review.
Infectious complications in SLE after immunosuppressive therapies.
Kang I, Park SH.
Curr Opin Rheumatol. 2003 Sep;15(5):528-34. Review.
[Systemic lupus erythematosus: future therapeutic avenues].
Amoura Z, Haroche J, Piette JC.
Rev Med Interne. 2008 Sep;29(9):718-24. Epub 2008 Jul 10. French.
New therapies in systemic lupus erythematosus.
Solsky MA, Wallace DJ.
Best Pract Res Clin Rheumatol. 2002 Apr;16(2):293-312. Review.
Emerging drug therapies for systemic lupus erythematosus.
Expert Opin Emerg Drugs. 2006 Nov;11(4):597-608. Review.
Treatment options for juvenile-onset systemic lupus erythematosus.
Carreño L, López-Longo FJ, González CM, Monteagudo I.
Paediatr Drugs. 2002;4(4):241-56. Review.
Development of biologicals for the therapy of lupus erythematosus.
Neumann D, Tschernig T, Boraschi D.
Expert Rev Vaccines. 2007 Dec;6(6):1001-11. Review.
Dehydroepiandrosterone and biologics in the treatment of systemic lupus erythematosus.
Furie R.
Curr Rheumatol Rep. 2000 Feb;2(1):44-50. Review.
Anti-DNA autoantibodies and systemic lupus erythematosus.
Blatt NB, Glick GD.
Pharmacol Ther. 1999 Aug;83(2):125-39. Review.
Immunotherapy of systemic lupus erythematosus.
O'Neill SG, Schrieber L.
Autoimmun Rev. 2005 Jul;4(6):395-402. Epub 2005 Apr 19. Review.
Re-evaluation of biologic therapies in systemic lupus erythematosus.
Bruce IN.
Curr Opin Rheumatol. 2010 May;22(3):273-7. Review.
New therapies in SLE.
Ferrera F, Filaci G, Rizzi M, Singh RP, Indiveri F, Hahn BH, La Cava A.
Recent Pat Inflamm Allergy Drug Discov. 2008 Jan;2(1):11-23. Review.
Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.
Yamamoto K, Okada Y, Nakamura K, Hiromura K, Nojima Y, Nakamura T.
Expert Opin Drug Saf. 2010 May;9(3):447-57. Review.
Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.
Marks SD, Tullus K.
Paediatr Drugs. 2007;9(6):371-8. Review.
The future of lupus therapy modulating autoantigen recognition.
Okamoto A, Fujio K, Yamamoto K.
Lupus. 2010 Oct;19(12):1474-81. Review.
New therapies for systemic lupus erythematosus.
Goldblatt F, Isenberg DA.
Clin Exp Immunol. 2005 May;140(2):205-12. Review.
Systemic lupus erythematosus: modern strategies for management: a moving target.
King JK, Hahn BH.
Best Pract Res Clin Rheumatol. 2007 Dec;21(6):971-87. Review.
Antibody-based therapies in systemic lupus erythematosus.
Iikuni N, La Cava A.
Mini Rev Med Chem. 2009 Jun;9(7):829-46. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on